Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Chorti, F. Drakopanagiotakis, N. Maouni, N. Trakas, E. P. Pierrakou, E. M. Antonogiannaki, M. Daimonakou, S. Legaki (Athens, Greece). Increased cytokeratin-19 expression in fibrotic interstitial lung disease. Eur Respir J 2010; 36: Suppl. 54, 4182

Member's Comments

No comment yet.

Related content which might interest you: KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Increased CCL18 production in interstitial lung diseases is associated with fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 38s Year: 2004 A clinicopathological review of interstitial pneumonia with marked IgG4 positive plasma cells infiltration Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Circulating fibrocytes in interstitial lung disease Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 αVβ6 integrin expression in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs) Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Aquoaporin-1 expression in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004 Alveoscopy in diffuse interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 244s Year: 2007 Differential gene expression of lung fibroblasts derived from UIP and NSIP patterns of interstitial lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 478s Year: 2002 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Increased BALF eosinophils and underlying interstitial lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013